Apollo Endosurgery (APEN) Misses Q4 EPS by 8c

Apollo Endosurgery (NASDAQ: APEN) reported Q4 EPS of ($0.42), $0.08 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.64 million.

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c